Pingora Partners’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$63.2K Hold
500
– – 0.04% 120
2026
Q1
$69.7K Hold
500
– – 0.04% 113
2025
Q4
$61.4K Hold
500
– – 0.04% 114
2025
Q3
$55.5K Hold
500
– – 0.04% 118
2025
Q2
$55.4K Hold
500
– – 0.04% 117
2025
Q1
$56K Sell
500
-200
-29% -$20.6K 0.04% 109
2024
Q4
$64.7K Hold
700
– – 0.04% 112
2024
Q3
$58.7K Hold
700
– – 0.04% 116
2024
Q2
$48K Hold
700
– – 0.03% 124
2024
Q1
$51.3K Buy
700
+200
+40% +$15.4K 0.04% 130
2023
Q4
$40.5K Buy
+500
New +$38.9K 0.04% 116

Other funds holding GILD

Pingora Partners's GILD Position: Q2 2026 in Review

Pingora Partners held its Gilead Sciences (GILD) position steady in Q2 2026 at 500 shares worth $63.2K. The position accounts for 0.04% of the portfolio, ranked #120.

Pingora Partners first reported a position in GILD in Q4 2023 and has held it in 11 quarters since. The position peaked at $69.7K in Q1 2026. 2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Pingora Partners held 500 shares of Gilead Sciences worth $63.2K as of Q2 2026.
  • Pingora Partners left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.04% of Pingora Partners's portfolio in Q2 2026, its #120 holding.
  • Pingora Partners first reported a position in Gilead Sciences in Q4 2023 and has held it in 11 quarters since.
  • Pingora Partners's Gilead Sciences position peaked at $69.7K in Q1 2026.
  • 2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Pingora Partners's 13F filing for Q2 2026, filed 14 Aug 2026.